{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Métastase lymphatique : Questions médicales les plus fréquentes",
"headline": "Métastase lymphatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Métastase lymphatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique",
"alternateName": "Lymphatic Metastasis",
"code": {
"@type": "MedicalCode",
"code": "D008207",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yanshi Li",
"url": "https://questionsmedicales.fr/author/Yanshi%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tao Lu",
"url": "https://questionsmedicales.fr/author/Tao%20Lu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Guohua Hu",
"url": "https://questionsmedicales.fr/author/Guohua%20Hu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tianxin Lin",
"url": "https://questionsmedicales.fr/author/Tianxin%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. Electronic address: lintx@mail.sysu.edu.cn."
}
},
{
"@type": "Person",
"name": "Changhao Chen",
"url": "https://questionsmedicales.fr/author/Changhao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A First-Person Account of Developmental Language Disorder.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37195674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_AJSLP-22-00247"
}
},
{
"@type": "ScholarlyArticle",
"name": "Review of intervention methods for language and communication disorders in children with autism spectrum disorders.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37576502",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationships Among Motor, First, and Second Language Skills Among Bilingual Children With Language Disorders.",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37532242",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_JSLHR-23-00043"
}
},
{
"@type": "ScholarlyArticle",
"name": "The significance of nonverbal performance in children with developmental language disorder.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35593196",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09297049.2022.2077324"
}
},
{
"@type": "ScholarlyArticle",
"name": "Abilities and Disabilities Among Children With Developmental Language Disorder.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37159846",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_LSHSS-22-00070"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
},
{
"@type": "ListItem",
"position": 5,
"name": "Métastase tumorale",
"item": "https://questionsmedicales.fr/mesh/D009362"
},
{
"@type": "ListItem",
"position": 6,
"name": "Métastase lymphatique",
"item": "https://questionsmedicales.fr/mesh/D008207"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Métastase lymphatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Métastase lymphatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Métastase lymphatique",
"description": "Comment diagnostiquer une métastase lymphatique ?\nQuels tests sont utilisés pour détecter des métastases ?\nQuels signes indiquent une métastase lymphatique ?\nPeut-on détecter des métastases par analyse sanguine ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Métastase lymphatique",
"description": "Quels sont les symptômes des métastases lymphatiques ?\nLes métastases lymphatiques causent-elles des douleurs ?\nPeut-on avoir des symptômes sans métastases visibles ?\nLes symptômes varient-ils selon le type de cancer ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Métastase lymphatique",
"description": "Peut-on prévenir les métastases lymphatiques ?\nQuels facteurs de risque augmentent les métastases ?\nL'alimentation influence-t-elle le risque de métastases ?\nLe dépistage régulier est-il important ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Métastase lymphatique",
"description": "Quels traitements sont disponibles pour les métastases lymphatiques ?\nLa radiothérapie est-elle efficace contre les métastases ?\nQuand la chirurgie est-elle recommandée ?\nQuels médicaments sont utilisés pour traiter les métastases ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Métastase lymphatique",
"description": "Quelles complications peuvent survenir avec les métastases ?\nLes métastases lymphatiques affectent-elles la fonction immunitaire ?\nComment les métastases impactent-elles la qualité de vie ?\nLes métastases peuvent-elles causer des problèmes respiratoires ?\nY a-t-il un risque d'infection avec les métastases ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Métastase lymphatique",
"description": "Quels cancers sont plus susceptibles de métastaser par voie lymphatique ?\nLe tabagisme est-il un facteur de risque ?\nL'âge influence-t-il le risque de métastases ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'obésité est-elle un facteur de risque pour les métastases ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Language+Development+Disorders&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une métastase lymphatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (IRM, TDM) et biopsie des ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter des métastases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la tomographie et la scintigraphie lymphatique."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une métastase lymphatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement des ganglions lymphatiques et des douleurs localisées peuvent indiquer des métastases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des métastases par analyse sanguine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines peuvent révéler des marqueurs tumoraux, mais ne suffisent pas pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie permet de visualiser l'étendue des métastases et d'évaluer les ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des métastases lymphatiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ganglions enflés, douleur, fatigue et perte de poids."
}
},
{
"@type": "Question",
"name": "Les métastases lymphatiques causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs localisées au niveau des ganglions touchés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans métastases visibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des symptômes sans métastases détectables par imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction du type de cancer primaire et de sa localisation."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec la progression de la maladie et l'extension des métastases."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les métastases lymphatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un dépistage précoce et un traitement efficace des cancers primaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les métastases ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le tabagisme et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de métastases ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine peut réduire le risque de cancer et donc de métastases lymphatiques."
}
},
{
"@type": "Question",
"name": "Le dépistage régulier est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier permet de détecter les cancers à un stade précoce, réduisant le risque de métastases."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les métastases lymphatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie ciblée."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace contre les métastases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut réduire la taille des métastases et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée si les métastases sont localisées et accessibles sans risque majeur."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter les métastases ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de tyrosine kinase et l'immunothérapie sont utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction du type de cancer et de l'état du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les métastases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'obstruction lymphatique, la douleur chronique et l'infection."
}
},
{
"@type": "Question",
"name": "Les métastases lymphatiques affectent-elles la fonction immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent compromettre la fonction immunitaire en affectant les ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Comment les métastases impactent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs, une fatigue accrue et des limitations fonctionnelles."
}
},
{
"@type": "Question",
"name": "Les métastases peuvent-elles causer des problèmes respiratoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elles se propagent aux ganglions lymphatiques thoraciques, cela peut affecter la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'infection avec les métastases ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les métastases peuvent augmenter le risque d'infections en compromettant le système lymphatique."
}
},
{
"@type": "Question",
"name": "Quels cancers sont plus susceptibles de métastaser par voie lymphatique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cancers du sein, du poumon et de la peau sont souvent associés à des métastases lymphatiques."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de plusieurs cancers, favorisant les métastases."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de métastases ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de métastases augmente avec l'âge en raison de la diminution de l'immunité."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer des métastases."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque pour les métastases ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à un risque accru de plusieurs cancers et de métastases."
}
}
]
}
]
}
The aim of this study is to share the lived experiences of an adult with developmental language disorder (DLD) and relate her experience to the evidence base and issues in clinical practice....
We co-wrote a first-person account grounded in the research literature. We organized the account into six main sections: (a) the early signs of DLD; (b) diagnosis; (c) treatment; (d) the impact of DLD...
The first author was diagnosed with moderate-to-severe DLD in early childhood, and she continues to exhibit subtle and occasional symptoms of DLD as an adult. At specific points in development, her fa...
In recent years, the number of patients-particularly children-with autism spectrum disorder (ASD) has been continually increasing. ASD affects a child's language communication and social interaction t...
The purpose of this study was to determine the significance and directions of the relationships among oral and manual fine motor skills and language abilities among Spanish-English bilingual children....
Participants included 56 bilingual children, 24 of whom met criteria for developmental language disorder (DLD), recruited based on teacher concern for language and/or reading comprehension abilities. ...
Oral fine motor abilities (diadochokinetic rate productions of /pa/ and /pata/) predicted Spanish (but not English) oral language abilities in the expected direction (i.e., faster rates were associate...
Oral fine motor abilities are related to language abilities in bilingual children, but only for the native language. We did not find reliable differences in oral and manual fine motor skills between g...
Nonverbal deficits are frequently reported in children with developmental language disorder (DLD). In the new diagnostic criteria of DLD, the previous requirement of normal nonverbal performance has b...
The aim of this study was to situate developmental language disorder (DLD) within the impairment and disability framework of the International Classification of Functioning, Disability, and Health (IC...
We queried the caregivers of 35 children with DLD and 44 peers with typical language development about their children's language-related functions, developmental risks, and language services using mix...
The children with DLD presented with weaknesses in domains that are highly dependent upon language skill, including communication, community function, interpersonal relationships, and academics. They ...
Children with DLD present with predictable strengths and weaknesses in everyday language-related functioning. For some children, the weaknesses are mild, but for others, they limit function to a great...
Children with delays in expressive language (late talkers) have heterogeneous developmental trajectories. Some are late bloomers who eventually "catch-up," but others have persisting delays or are lat...
The receptive language ability of individuals with autism spectrum disorder (ASD) seems to lag behind expressive language ability. Several autism-related genes may influence this developmental delay. ...
We included 59 children with ASD and 57 children with typical development in this study and investigated this association using coarse-grained exact matching....
We present the first evidence of an association between CNTNAP2 rs2710102 (A-allele carrier) and reduced receptive language ability in children with ASD whose language development was not delayed. Sim...
It is possible that the effect of rs2710102 on receptive language ability is larger in the presence of autism-related genes. Consequently, we speculate that the effect of rs2710102 on receptive langua...
Early and effective treatment for children with developmental language disorder (DLD) is important. Although a growing body of research shows the effects of interventions at the group level, clinician...
To assess changes in the language domains: expressive morphosyntax; receptive and expressive vocabulary; and comprehension, in children in special needs education for DLD. To explore if differences in...
We extracted data from school records of 154 children (4-6 years old) in special needs education offering a language and communication-stimulating educational environment, including speech and languag...
Overall, the children showed significant improvements in expressive morphosyntax, expressive vocabulary and language comprehension. Baseline scores and gains were lowest for expressive morphosyntax. D...
Children with DLD in special needs education showed gains in language performance during one school year. There was, however, little change in morphosyntactic scores, which supports previous studies c...
What is already known on the subject Intervention studies indicate that intervention can be effective, but not for all children with DLD, and not in all language domains. Longitudinal studies on langu...
The nature of auditory processing problems in children with developmental language disorder (DLD) is still poorly understood. Much research has been devoted to determining the extent to which DLD is a...
Previous research, although scarce, has indicated that the general public is still relatively unaware of developmental language disorder (DLD), one of the most common (neuro)developmental disorders. R...
To examine public awareness of DLD in the neighbouring countries of Croatia, Italy and Slovenia, as well as to assess the influence of age, gender and education level on that awareness. Also, to inves...
A convenience sample of adults living in the countries of the Adriatic region-Croatia (N = 92), Italy (N = 105) and Slovenia (N = 90)-were asked to fill out a paper-and-pencil questionnaire (public su...
Public awareness of DLD is still unsatisfactory in all three countries. Around 70% of respondents reported having heard of DLD; however, only around 20% of Croatian, 40% of Italian and 5% of Slovenian...
Public awareness of DLD varies substantially among the three countries, but there is space for improvement in each of them. The findings of this study build on the existing data from the international...
What is already known on the subject DLD is one of the most common (neuro)developmental disorders, yet it is not well known to the general public. This low awareness hinders timely recognition and ade...